Biglycan
Biglycan[edit]
Biglycan is a small leucine-rich proteoglycan (SLRP) that is encoded by the BGN gene in humans. It is a member of the class I SLRP family and plays a crucial role in the structural integrity and function of various tissues. Biglycan is involved in the organization of the extracellular matrix (ECM) and interacts with several other matrix components and cell surface receptors.
Structure[edit]
Biglycan is characterized by a core protein that is approximately 42 kDa in size, which is decorated with glycosaminoglycan (GAG) chains, typically chondroitin sulfate or dermatan sulfate. The core protein consists of leucine-rich repeats (LRRs), which are responsible for its interactions with other proteins and molecules in the ECM.
Function[edit]
Biglycan plays a significant role in the assembly and maintenance of the ECM. It binds to collagen fibrils, influencing their organization and stability. Additionally, biglycan interacts with growth factors, such as transforming growth factor-beta (TGF-β), modulating their activity and availability.
Role in Bone and Cartilage[edit]
In bone and cartilage, biglycan is essential for normal skeletal development. It regulates the mineralization process and affects the differentiation of osteoblasts and chondrocytes. Mutations or deficiencies in biglycan can lead to skeletal dysplasias and other connective tissue disorders.
Role in Muscle[edit]
Biglycan is also expressed in muscle tissue, where it interacts with dystrophin and other components of the dystrophin-glycoprotein complex. This interaction is crucial for maintaining muscle integrity and function. Deficiencies in biglycan have been associated with muscular dystrophies.
Clinical Significance[edit]
Mutations in the BGN gene can lead to X-linked spondyloepimetaphyseal dysplasia (X-linked SEMD), a condition characterized by skeletal abnormalities. Biglycan has also been implicated in the pathogenesis of osteoarthritis and other degenerative diseases due to its role in ECM homeostasis.
Research and Therapeutic Potential[edit]
Biglycan is a subject of interest in regenerative medicine and tissue engineering. Its ability to modulate ECM components and growth factors makes it a potential target for therapies aimed at repairing or regenerating damaged tissues.
See Also[edit]
References[edit]
<references/>
External Links[edit]
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian